Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Breast Neoplasms: HELP
Anne-sophie Hamy
Based on 21 articles published since 2010
(Why 21 articles?)
||||
Expertise Level
The expertise of Anne-sophie Hamy ranks in the
  • Top 0.83%
  • ... of 273,648 published authors worldwide on Breast Neoplasms
  • ... from 2010 through 2020
  • ... based on contributions to 21 articles on the topic.
Graphical view (beta)
Get your prestigious
Expert badge
similar to this:
 
Aliases Hamy, A-S   ·   Hamy, Anne-sophie   ·   Hamy, A S   ·   Hamy, Anne-Sophie
Work Locations
Details
Most likely:    Institut Curie      
2019
  • Université Libre de Bruxelles, Institut Jules Bordet, Bruxelles, Belgium. · Residual Tumor & Response to Treatment Laboratory, PSL Research University, Paris, France. · Breast and Gynecologic Cancer and Reconstructive Surgery Team, Institut Curie, Paris, France. · Pubmed 31231570
  • Institut Curie, PSL Research University, Paris, France. · Immunity and Cancer, Integrative Biology of Human Dendritic Cells and T Cells Laboratory, UMR 932 Immunity and Cancer, INSERM, Paris, France. · Stress and cancer laboratory, U830 Genetics and Biology of cancers, INSERM, Paris, France. · U900, Unit of biometry, INSERM, Paris, France. · Departement of translational research, Residual tumor and response to treatment laboratory (RT2Lab), UMR 932 Immunity and Cancer, INSERM, Paris, France. · Departement of Surgical Oncology, Institut Curie, Paris, France. · Diagnostic and Theranostic medicine division, Institut Curie, Paris, France. · Department of Biopathology, U934, INSERM, Paris, France. · Center of Clinical Investigation, CIC IGR-Curie 1428, Paris, France. · Pubmed 31428522
  • Department of Surgery, Institut Curie, Paris, France. · Residual Tumour & Response to Treatment Laboratory, RT2Lab, PSL Research University, Translational Research Department, Institut Curie, Paris, France. · INSERM, U932 Immunity and Cancer, Paris, France. · Department of Surgery, Institut Gustave Roussy, Villejuif, France. · Department of Gynaecology and Obstetrics, Geneva University Hospitals, Geneva, Switzerland. · Department of Medical Oncology, Institut Curie, Paris, France. · Paris Descartes University, Paris, France. · Pubmed 30673703
2018
  • Residual Tumor and Response to Treatment Laboratory, RT2Lab, PSL Research University, INSERM, U932 Immunity and Cancer, Institut Curie, Paris, France. · Breast and Gynecologic Cancer and Reconstructive Surgery Team, Institut Curie, Paris, France. · Institut Jules Bordet, Université Libre de Bruxelles, Bruxelles, Belgium. · Pubmed 29862051
  • Molecular Oncology Unit, Assistance Publique-Hôpitaux de Paris, University Saint-Louis Hospital, Paris, France · University Paris-Diderot, Sorbonne Paris Cité, INSERM/CNRS UMR944/7212, Paris, France. · PSL Research University, Translational Research Department INSERM U932, Immunity and Cancer, Residual Tumor & Response to Treatment Laboratory (RT2 Lab), Curie Institute, Paris, France. · Molecular Oncology Unit, Assistance Publique-Hôpitaux de Paris, University Saint-Louis Hospital, Paris, France. · Translational Research Laboratory, Gustave Roussy Cancer Center, Villejuif, France. · Pathology Department, Curie Institute, Paris, France. · Pathology Department, Gustave Roussy Cancer Center, Villejuif, France. · Pathology Department, Assistance Publique-Hôpitaux de Paris, University Saint-Louis Hospital, Paris, France. · Tumor Biology Department, Curie Institute, Saint-Cloud, France. · Medical Oncology Department, Curie Institute, Paris, France. · University Paris-Descartes, Sorbonne Paris Cité, Paris, France. · Breast Disease Unit, Assistance Publique-Hôpitaux de Paris, University Saint-Louis Hospital, Paris, France. · Medical Oncology Department, Curie Institute, Saint-Cloud, France. · Centre for Therapeutic Innovations in Oncology and Hematology, Assistance Publique-Hôpitaux de Paris, Saint-Louis Hospital, Paris, France. · UMR 8081 "IM4R", Université Paris Sud, Paris, France. · Pharmacogenomics Unit, Curie Institute, Paris, France. · Pubmed 29491076
  • Department of Surgery, Institut Curie, 26 rue d'Ulm, 75005 Paris, France. Electronic address: · Department of Surgery, Institut Curie, 26 rue d'Ulm, 75005 Paris, France. Electronic address: · Department of Pathology, Centre René Huguenin- Institut Curie, 35 Rue Dailly, 92210 St Cloud, France. Electronic address: · Department of Surgery, Institut Curie, 26 rue d'Ulm, 75005 Paris, France. Electronic address: · Port-Royal Maternity Unit, 123 Boulevard de Port Royal, 75014 Paris, France. Electronic address: · Department of Surgery, Institut Curie, 26 rue d'Ulm, 75005 Paris, France. Electronic address: · Department of Gynecology and Obstetrics, Geneva University Hospitals, Rue Gabrielle-Perret-Gentil 4, 1205 Geneva, Switzerland. Electronic address: · Department of Pathology, Centre René Huguenin- Institut Curie, 35 Rue Dailly, 92210 St Cloud, France. Electronic address: · Department of Surgery, Institut Curie, 26 rue d'Ulm, 75005 Paris, France; Residual Tumor & Response to Treatment Laboratory, RT2Lab, Translational Research Department, PSL Research University, INSERM, U932 Immunity and Cancer, Institut Curie, 26 rue d'Ulm, Paris, France. Electronic address: · Residual Tumor & Response to Treatment Laboratory, RT2Lab, Translational Research Department, PSL Research University, INSERM, U932 Immunity and Cancer, Institut Curie, 26 rue d'Ulm, Paris, France. Electronic address: · Pubmed 30179779
  • Translational Research Department, INSERM, U932, Immunity and Cancer, Residual Tumor & Response to Treatment Laboratory, RT2Lab, Institut Curie, PSL Research University, 26, rue d'Ulm, 75248, Paris, France. · Department of Surgery, Institut Curie, PSL Research University, 26 rue d'Ulm, 75248, Paris, France. · Department of Gynecology and Obstetrics, Geneva University Hospitals, 30 bd de la Cluse, 1205, Geneva, Switzerland. · Department of Medical Informatics and Data, Institut Curie, PSL Research University, 26 rue d'Ulm, 75248, Paris, France. · Department of Medical Oncology, Institut Curie, PSL Research University, 26 rue d'Ulm, 75248, Paris, France. · Department of Pathology, Institut Curie, PSL Research University, 26 rue d'Ulm, 75248, Paris, France. · Department of Medical Oncology, Hôpital René Huguenin, 35, rue Dailly, 92210, Saint-Cloud, France. · Department of Pathology, Hôpital René Huguenin, 35, rue Dailly, 92210, Saint-Cloud, France. · Department of Surgery, Hôpital René Huguenin, 35, rue Dailly, 92210, Saint-Cloud, France. · Equipe d'Accueil 7285, Risk and Safety in Clinical Medicine for Women and Perinatal Health, University Versailles-Saint-Quentin, 2 av de la source de la Bièvre, 78180, Montigny-Le-Bretonneux, France. · Translational Research Department, INSERM, U932, Immunity and Cancer, Residual Tumor & Response to Treatment Laboratory, RT2Lab, Institut Curie, PSL Research University, 26, rue d'Ulm, 75248, Paris, France. · Department of Surgery, Institut Curie, PSL Research University, 26 rue d'Ulm, 75248, Paris, France. · Pubmed 29374852
2017
  • AP-HP, Hôpital Saint-Louis, Breast Disease Unit, University Paris Diderot, 75475 Paris, France. Electronic address: · Institut Curie, PSL Research University, Translational Research Department, INSERM, U932 Immunity and Cancer, Residual Tumor & Response to Treatment Laboratory (RT2Lab), Paris, France. · Medical Oncology Department, Gustave Roussy, Cancer Center Villejuif, France. · Medical Oncology Department, Institut Curie, Saint Cloud, Paris, France. · Biostatistics Department, Institut Curie, Paris, France. · Tumor Biology Department, Institut Curie, Saint Cloud, Paris, France. · Pathology Department, Gustave Roussy, Cancer Center Villejuif, France. · AP-HP, Hôpital Saint-Louis, Pathology Department, University Paris Diderot, Paris, France. · Department of Surgery, Gustave Roussy, Cancer Center Villejuif, France. · Center for Therapeutic Innovations in Oncology and Haematology (CITOH), APHP, Hôpital Saint-Louis, Paris, France. · AP-HP, Hôpital Saint-Louis, Breast Disease Unit, University Paris Diderot, 75475 Paris, France. · Institut Curie, PSL Research University, Translational Research Department, INSERM, U932 Immunity and Cancer, Residual Tumor & Response to Treatment Laboratory (RT2Lab), Paris, France; Department of Surgery, Institut Curie, Paris, France. · AP-HP, Hôpital Saint-Louis, Breast Disease Unit, University Paris Diderot, 75475 Paris, France; Center for Therapeutic Innovations in Oncology and Haematology (CITOH), APHP, Hôpital Saint-Louis, Paris, France. · UMR 8081 'IR4M', Université Paris-Sud, 91400 Orsay, France. · Medical Oncology Department, Institut Curie, Saint Cloud, Paris, France; Université Paris Descartes, Sorbonne Paris Cite, Paris, France. · Pubmed 28279941
  • Residual Tumor & Response to Treatment Laboratory, RT2Lab, Translational Research Department, PSL Research University, Institut Curie, Paris. · INSERM, U932 Immunity and Cancer, Paris. · Department of Medical Oncology, Institut Curie, Paris. · Faculty of Medicine, Paris Descartes University, Paris. · Departments of Surgery, Institut Curie, Paris. · Department of Pathology, Institut Curie, Paris, France. · Equipe d'Accueil 7285, Risk and Safety in Clinical Medicine for Women and Perinatal Health, University Versailles-Saint-Quentin, 2 av de la source de la Biévre, 78180 Montigny-le-Bretonneux, France. · Pubmed 28911063
2016
  • Institut Curie, PSL Research University, Translational Research Department, INSERM, U932 Immunity and Cancer, Residual Tumor & Response to Treatment Laboratory (RT2Lab), Paris, France. · Department of Surgery, Institut Curie, Paris, France. · Department of Tumor Biology, Institut Curie, Paris, France. · Mines Paristech, PSL-Research University, CBIO-Centre for Computational Biology, Mines ParisTech, Fontainebleau, France. · U900, INSERM, Institut Curie, Paris, France. · Laboratoire de Mathématiques et Modélisation d'Evry, Université d'Évry Val d'Essonne, Evry, France. · Pubmed 28005906
  • Department of Biostatistics, Institut Curie, Paris, France. · Pharmacogenomics Unit, Department of Genetics, Institut Curie, Paris, France. · APHP Molecular Oncology Unit, Hôpital Saint Louis, Paris Diderot University, 1 Avenue Claude Vellefaux, 75010, Paris, France. · Biology Department, Institut Gustave Roussy, Villejuif, France. · APHP Pathology Department, Hôpital Saint Louis, Paris Diderot University, Paris, France. · Pathology Department, Hôpital René-Huguenin, Institut Curie, Saint-Cloud, France. · Pathology Department, Institut Gustave Roussy, Villejuif, France. · Pathology Department, Institut Curie, Paris, France. · APHP, Centre for Therapeutic Innovation, Saint-Louis Hospital, Paris, France. · APHP Molecular Oncology Unit, Hôpital Saint Louis, Paris Diderot University, 1 Avenue Claude Vellefaux, 75010, Paris, France. · Pubmed 27592112
  • Department of Surgery, Institut Curie, 75005, Paris, France. · Breast Unit, Belfast City Hospital, Lisburn Road, Belfast, BT9 7AB, Northern Ireland. · Department of Medical Oncology, 75005, Institut Curie, Paris, France. · Paris Descartes University, 75006, Paris, France. · Department of Tumor Biology, Institut Curie, 75005, Paris, France. · Department of Radiotherapy, Institut Curie, 75005, Paris, France. · Residual Tumor and Response to Treatment Lab, Translational Research Department, Institut Curie, 75005, Paris, France. · UMR932 Immunity and Cancer, INSERM, Institut Curie, 75005, Paris, France. · Pubmed 27494111
  • Institut Curie, PSL Research University, Translational Research Department, INSERM, U932 Immunity and Cancer, Residual Tumor & Response to Treatment Laboratory (RT2Lab), F-75248, Paris, France. · Biostatistics Department, Institut Curie, Paris 75005, France. · Department of Surgery, Institut Curie, Paris F-75248, France. · Department of Medical Oncology, Institut Curie, Paris, France. · Department of Tumor Biology, Institut Curie, Paris 75005, France. · Pubmed 26657653
2014
  • Department of Nuclear Medicine, Saint-Louis Hospital, Paris, France; B2T, Doctoral School, IUH, University of Paris VII, France. Electronic address: · Department of Nuclear Medicine, CHU Bordeaux, University of Bordeaux, France. · Breast Diseases Unit and Department of Medical Oncology, Saint-Louis Hospital, Paris, France. · Breast Diseases Unit and Department of Medical Oncology, Saint-Louis Hospital, Paris, France; Department of Biostatistics, Institut Curie, Paris, France. · Department of Biostatistics, Institut Curie, Paris, France. · Department of Nuclear Medicine, Saint-Louis Hospital, Paris, France; B2T, Doctoral School, IUH, University of Paris VII, France. · Department of Pathology, Saint-Louis Hospital, Paris, France. · Department of Biochemistry, Saint-Louis Hospital, Paris, France. · Breast Diseases Unit and Department of Medical Oncology, Saint-Louis Hospital, Paris, France; Centre for Therapeutic Innovation, Saint Louis Hospital, Paris, France. · INSERM, UMR 1101 LaTIM, Brest, France. · Pubmed 24841218
Probable:    Sorbonne University      
2019
  • Institut Curie, PSL Research University, Paris, France. · Immunity and Cancer, Integrative Biology of Human Dendritic Cells and T Cells Laboratory, UMR 932 Immunity and Cancer, INSERM, Paris, France. · Stress and cancer laboratory, U830 Genetics and Biology of cancers, INSERM, Paris, France. · U900, Unit of biometry, INSERM, Paris, France. · Departement of translational research, Residual tumor and response to treatment laboratory (RT2Lab), UMR 932 Immunity and Cancer, INSERM, Paris, France. · Departement of Surgical Oncology, Institut Curie, Paris, France. · Diagnostic and Theranostic medicine division, Institut Curie, Paris, France. · Department of Biopathology, U934, INSERM, Paris, France. · Center of Clinical Investigation, CIC IGR-Curie 1428, Paris, France. · Pubmed 31428522
  • Department of Surgery, Institut Curie, Paris, France. · Residual Tumour & Response to Treatment Laboratory, RT2Lab, PSL Research University, Translational Research Department, Institut Curie, Paris, France. · INSERM, U932 Immunity and Cancer, Paris, France. · Department of Surgery, Institut Gustave Roussy, Villejuif, France. · Department of Gynaecology and Obstetrics, Geneva University Hospitals, Geneva, Switzerland. · Department of Medical Oncology, Institut Curie, Paris, France. · Paris Descartes University, Paris, France. · Pubmed 30673703
2018
  • Molecular Oncology Unit, Assistance Publique-Hôpitaux de Paris, University Saint-Louis Hospital, Paris, France · University Paris-Diderot, Sorbonne Paris Cité, INSERM/CNRS UMR944/7212, Paris, France. · PSL Research University, Translational Research Department INSERM U932, Immunity and Cancer, Residual Tumor & Response to Treatment Laboratory (RT2 Lab), Curie Institute, Paris, France. · Molecular Oncology Unit, Assistance Publique-Hôpitaux de Paris, University Saint-Louis Hospital, Paris, France. · Translational Research Laboratory, Gustave Roussy Cancer Center, Villejuif, France. · Pathology Department, Curie Institute, Paris, France. · Pathology Department, Gustave Roussy Cancer Center, Villejuif, France. · Pathology Department, Assistance Publique-Hôpitaux de Paris, University Saint-Louis Hospital, Paris, France. · Tumor Biology Department, Curie Institute, Saint-Cloud, France. · Medical Oncology Department, Curie Institute, Paris, France. · University Paris-Descartes, Sorbonne Paris Cité, Paris, France. · Breast Disease Unit, Assistance Publique-Hôpitaux de Paris, University Saint-Louis Hospital, Paris, France. · Medical Oncology Department, Curie Institute, Saint-Cloud, France. · Centre for Therapeutic Innovations in Oncology and Hematology, Assistance Publique-Hôpitaux de Paris, Saint-Louis Hospital, Paris, France. · UMR 8081 "IM4R", Université Paris Sud, Paris, France. · Pharmacogenomics Unit, Curie Institute, Paris, France. · Pubmed 29491076
  • Department of Surgery, Institut Curie, 26 rue d'Ulm, 75005 Paris, France. Electronic address: · Department of Surgery, Institut Curie, 26 rue d'Ulm, 75005 Paris, France. Electronic address: · Department of Pathology, Centre René Huguenin- Institut Curie, 35 Rue Dailly, 92210 St Cloud, France. Electronic address: · Department of Surgery, Institut Curie, 26 rue d'Ulm, 75005 Paris, France. Electronic address: · Port-Royal Maternity Unit, 123 Boulevard de Port Royal, 75014 Paris, France. Electronic address: · Department of Surgery, Institut Curie, 26 rue d'Ulm, 75005 Paris, France. Electronic address: · Department of Gynecology and Obstetrics, Geneva University Hospitals, Rue Gabrielle-Perret-Gentil 4, 1205 Geneva, Switzerland. Electronic address: · Department of Pathology, Centre René Huguenin- Institut Curie, 35 Rue Dailly, 92210 St Cloud, France. Electronic address: · Department of Surgery, Institut Curie, 26 rue d'Ulm, 75005 Paris, France; Residual Tumor & Response to Treatment Laboratory, RT2Lab, Translational Research Department, PSL Research University, INSERM, U932 Immunity and Cancer, Institut Curie, 26 rue d'Ulm, Paris, France. Electronic address: · Residual Tumor & Response to Treatment Laboratory, RT2Lab, Translational Research Department, PSL Research University, INSERM, U932 Immunity and Cancer, Institut Curie, 26 rue d'Ulm, Paris, France. Electronic address: · Pubmed 30179779
  • Translational Research Department, INSERM, U932, Immunity and Cancer, Residual Tumor & Response to Treatment Laboratory, RT2Lab, Institut Curie, PSL Research University, 26, rue d'Ulm, 75248, Paris, France. · Department of Surgery, Institut Curie, PSL Research University, 26 rue d'Ulm, 75248, Paris, France. · Department of Gynecology and Obstetrics, Geneva University Hospitals, 30 bd de la Cluse, 1205, Geneva, Switzerland. · Department of Medical Informatics and Data, Institut Curie, PSL Research University, 26 rue d'Ulm, 75248, Paris, France. · Department of Medical Oncology, Institut Curie, PSL Research University, 26 rue d'Ulm, 75248, Paris, France. · Department of Pathology, Institut Curie, PSL Research University, 26 rue d'Ulm, 75248, Paris, France. · Department of Medical Oncology, Hôpital René Huguenin, 35, rue Dailly, 92210, Saint-Cloud, France. · Department of Pathology, Hôpital René Huguenin, 35, rue Dailly, 92210, Saint-Cloud, France. · Department of Surgery, Hôpital René Huguenin, 35, rue Dailly, 92210, Saint-Cloud, France. · Equipe d'Accueil 7285, Risk and Safety in Clinical Medicine for Women and Perinatal Health, University Versailles-Saint-Quentin, 2 av de la source de la Bièvre, 78180, Montigny-Le-Bretonneux, France. · Translational Research Department, INSERM, U932, Immunity and Cancer, Residual Tumor & Response to Treatment Laboratory, RT2Lab, Institut Curie, PSL Research University, 26, rue d'Ulm, 75248, Paris, France. · Department of Surgery, Institut Curie, PSL Research University, 26 rue d'Ulm, 75248, Paris, France. · Pubmed 29374852
2017
  • AP-HP, Hôpital Saint-Louis, Breast Disease Unit, University Paris Diderot, 75475 Paris, France. Electronic address: · Institut Curie, PSL Research University, Translational Research Department, INSERM, U932 Immunity and Cancer, Residual Tumor & Response to Treatment Laboratory (RT2Lab), Paris, France. · Medical Oncology Department, Gustave Roussy, Cancer Center Villejuif, France. · Medical Oncology Department, Institut Curie, Saint Cloud, Paris, France. · Biostatistics Department, Institut Curie, Paris, France. · Tumor Biology Department, Institut Curie, Saint Cloud, Paris, France. · Pathology Department, Gustave Roussy, Cancer Center Villejuif, France. · AP-HP, Hôpital Saint-Louis, Pathology Department, University Paris Diderot, Paris, France. · Department of Surgery, Gustave Roussy, Cancer Center Villejuif, France. · Center for Therapeutic Innovations in Oncology and Haematology (CITOH), APHP, Hôpital Saint-Louis, Paris, France. · AP-HP, Hôpital Saint-Louis, Breast Disease Unit, University Paris Diderot, 75475 Paris, France. · Institut Curie, PSL Research University, Translational Research Department, INSERM, U932 Immunity and Cancer, Residual Tumor & Response to Treatment Laboratory (RT2Lab), Paris, France; Department of Surgery, Institut Curie, Paris, France. · AP-HP, Hôpital Saint-Louis, Breast Disease Unit, University Paris Diderot, 75475 Paris, France; Center for Therapeutic Innovations in Oncology and Haematology (CITOH), APHP, Hôpital Saint-Louis, Paris, France. · UMR 8081 'IR4M', Université Paris-Sud, 91400 Orsay, France. · Medical Oncology Department, Institut Curie, Saint Cloud, Paris, France; Université Paris Descartes, Sorbonne Paris Cite, Paris, France. · Pubmed 28279941
  • Residual Tumor & Response to Treatment Laboratory, RT2Lab, Translational Research Department, PSL Research University, Institut Curie, Paris. · INSERM, U932 Immunity and Cancer, Paris. · Department of Medical Oncology, Institut Curie, Paris. · Faculty of Medicine, Paris Descartes University, Paris. · Departments of Surgery, Institut Curie, Paris. · Department of Pathology, Institut Curie, Paris, France. · Equipe d'Accueil 7285, Risk and Safety in Clinical Medicine for Women and Perinatal Health, University Versailles-Saint-Quentin, 2 av de la source de la Biévre, 78180 Montigny-le-Bretonneux, France. · Pubmed 28911063
2016
  • Institut Curie, PSL Research University, Translational Research Department, INSERM, U932 Immunity and Cancer, Residual Tumor & Response to Treatment Laboratory (RT2Lab), Paris, France. · Department of Surgery, Institut Curie, Paris, France. · Department of Tumor Biology, Institut Curie, Paris, France. · Mines Paristech, PSL-Research University, CBIO-Centre for Computational Biology, Mines ParisTech, Fontainebleau, France. · U900, INSERM, Institut Curie, Paris, France. · Laboratoire de Mathématiques et Modélisation d'Evry, Université d'Évry Val d'Essonne, Evry, France. · Pubmed 28005906
  • Institut Curie, PSL Research University, Translational Research Department, INSERM, U932 Immunity and Cancer, Residual Tumor & Response to Treatment Laboratory (RT2Lab), F-75248, Paris, France. · Biostatistics Department, Institut Curie, Paris 75005, France. · Department of Surgery, Institut Curie, Paris F-75248, France. · Department of Medical Oncology, Institut Curie, Paris, France. · Department of Tumor Biology, Institut Curie, Paris 75005, France. · Pubmed 26657653
Probable:    INSERM France      
2019
  • Institut Curie, PSL Research University, Paris, France. · Immunity and Cancer, Integrative Biology of Human Dendritic Cells and T Cells Laboratory, UMR 932 Immunity and Cancer, INSERM, Paris, France. · Stress and cancer laboratory, U830 Genetics and Biology of cancers, INSERM, Paris, France. · U900, Unit of biometry, INSERM, Paris, France. · Departement of translational research, Residual tumor and response to treatment laboratory (RT2Lab), UMR 932 Immunity and Cancer, INSERM, Paris, France. · Departement of Surgical Oncology, Institut Curie, Paris, France. · Diagnostic and Theranostic medicine division, Institut Curie, Paris, France. · Department of Biopathology, U934, INSERM, Paris, France. · Center of Clinical Investigation, CIC IGR-Curie 1428, Paris, France. · Pubmed 31428522
  • Department of Surgery, Institut Curie, Paris, France. · Residual Tumour & Response to Treatment Laboratory, RT2Lab, PSL Research University, Translational Research Department, Institut Curie, Paris, France. · INSERM, U932 Immunity and Cancer, Paris, France. · Department of Surgery, Institut Gustave Roussy, Villejuif, France. · Department of Gynaecology and Obstetrics, Geneva University Hospitals, Geneva, Switzerland. · Department of Medical Oncology, Institut Curie, Paris, France. · Paris Descartes University, Paris, France. · Pubmed 30673703
2018
  • Molecular Oncology Unit, Assistance Publique-Hôpitaux de Paris, University Saint-Louis Hospital, Paris, France · University Paris-Diderot, Sorbonne Paris Cité, INSERM/CNRS UMR944/7212, Paris, France. · PSL Research University, Translational Research Department INSERM U932, Immunity and Cancer, Residual Tumor & Response to Treatment Laboratory (RT2 Lab), Curie Institute, Paris, France. · Molecular Oncology Unit, Assistance Publique-Hôpitaux de Paris, University Saint-Louis Hospital, Paris, France. · Translational Research Laboratory, Gustave Roussy Cancer Center, Villejuif, France. · Pathology Department, Curie Institute, Paris, France. · Pathology Department, Gustave Roussy Cancer Center, Villejuif, France. · Pathology Department, Assistance Publique-Hôpitaux de Paris, University Saint-Louis Hospital, Paris, France. · Tumor Biology Department, Curie Institute, Saint-Cloud, France. · Medical Oncology Department, Curie Institute, Paris, France. · University Paris-Descartes, Sorbonne Paris Cité, Paris, France. · Breast Disease Unit, Assistance Publique-Hôpitaux de Paris, University Saint-Louis Hospital, Paris, France. · Medical Oncology Department, Curie Institute, Saint-Cloud, France. · Centre for Therapeutic Innovations in Oncology and Hematology, Assistance Publique-Hôpitaux de Paris, Saint-Louis Hospital, Paris, France. · UMR 8081 "IM4R", Université Paris Sud, Paris, France. · Pharmacogenomics Unit, Curie Institute, Paris, France. · Pubmed 29491076
  • Department of Surgery, Institut Curie, 26 rue d'Ulm, 75005 Paris, France. Electronic address: · Department of Surgery, Institut Curie, 26 rue d'Ulm, 75005 Paris, France. Electronic address: · Department of Pathology, Centre René Huguenin- Institut Curie, 35 Rue Dailly, 92210 St Cloud, France. Electronic address: · Department of Surgery, Institut Curie, 26 rue d'Ulm, 75005 Paris, France. Electronic address: · Port-Royal Maternity Unit, 123 Boulevard de Port Royal, 75014 Paris, France. Electronic address: · Department of Surgery, Institut Curie, 26 rue d'Ulm, 75005 Paris, France. Electronic address: · Department of Gynecology and Obstetrics, Geneva University Hospitals, Rue Gabrielle-Perret-Gentil 4, 1205 Geneva, Switzerland. Electronic address: · Department of Pathology, Centre René Huguenin- Institut Curie, 35 Rue Dailly, 92210 St Cloud, France. Electronic address: · Department of Surgery, Institut Curie, 26 rue d'Ulm, 75005 Paris, France; Residual Tumor & Response to Treatment Laboratory, RT2Lab, Translational Research Department, PSL Research University, INSERM, U932 Immunity and Cancer, Institut Curie, 26 rue d'Ulm, Paris, France. Electronic address: · Residual Tumor & Response to Treatment Laboratory, RT2Lab, Translational Research Department, PSL Research University, INSERM, U932 Immunity and Cancer, Institut Curie, 26 rue d'Ulm, Paris, France. Electronic address: · Pubmed 30179779
  • Translational Research Department, INSERM, U932, Immunity and Cancer, Residual Tumor & Response to Treatment Laboratory, RT2Lab, Institut Curie, PSL Research University, 26, rue d'Ulm, 75248, Paris, France. · Department of Surgery, Institut Curie, PSL Research University, 26 rue d'Ulm, 75248, Paris, France. · Department of Gynecology and Obstetrics, Geneva University Hospitals, 30 bd de la Cluse, 1205, Geneva, Switzerland. · Department of Medical Informatics and Data, Institut Curie, PSL Research University, 26 rue d'Ulm, 75248, Paris, France. · Department of Medical Oncology, Institut Curie, PSL Research University, 26 rue d'Ulm, 75248, Paris, France. · Department of Pathology, Institut Curie, PSL Research University, 26 rue d'Ulm, 75248, Paris, France. · Department of Medical Oncology, Hôpital René Huguenin, 35, rue Dailly, 92210, Saint-Cloud, France. · Department of Pathology, Hôpital René Huguenin, 35, rue Dailly, 92210, Saint-Cloud, France. · Department of Surgery, Hôpital René Huguenin, 35, rue Dailly, 92210, Saint-Cloud, France. · Equipe d'Accueil 7285, Risk and Safety in Clinical Medicine for Women and Perinatal Health, University Versailles-Saint-Quentin, 2 av de la source de la Bièvre, 78180, Montigny-Le-Bretonneux, France. · Translational Research Department, INSERM, U932, Immunity and Cancer, Residual Tumor & Response to Treatment Laboratory, RT2Lab, Institut Curie, PSL Research University, 26, rue d'Ulm, 75248, Paris, France. · Department of Surgery, Institut Curie, PSL Research University, 26 rue d'Ulm, 75248, Paris, France. · Pubmed 29374852
2017
  • AP-HP, Hôpital Saint-Louis, Breast Disease Unit, University Paris Diderot, 75475 Paris, France. Electronic address: · Institut Curie, PSL Research University, Translational Research Department, INSERM, U932 Immunity and Cancer, Residual Tumor & Response to Treatment Laboratory (RT2Lab), Paris, France. · Medical Oncology Department, Gustave Roussy, Cancer Center Villejuif, France. · Medical Oncology Department, Institut Curie, Saint Cloud, Paris, France. · Biostatistics Department, Institut Curie, Paris, France. · Tumor Biology Department, Institut Curie, Saint Cloud, Paris, France. · Pathology Department, Gustave Roussy, Cancer Center Villejuif, France. · AP-HP, Hôpital Saint-Louis, Pathology Department, University Paris Diderot, Paris, France. · Department of Surgery, Gustave Roussy, Cancer Center Villejuif, France. · Center for Therapeutic Innovations in Oncology and Haematology (CITOH), APHP, Hôpital Saint-Louis, Paris, France. · AP-HP, Hôpital Saint-Louis, Breast Disease Unit, University Paris Diderot, 75475 Paris, France. · Institut Curie, PSL Research University, Translational Research Department, INSERM, U932 Immunity and Cancer, Residual Tumor & Response to Treatment Laboratory (RT2Lab), Paris, France; Department of Surgery, Institut Curie, Paris, France. · AP-HP, Hôpital Saint-Louis, Breast Disease Unit, University Paris Diderot, 75475 Paris, France; Center for Therapeutic Innovations in Oncology and Haematology (CITOH), APHP, Hôpital Saint-Louis, Paris, France. · UMR 8081 'IR4M', Université Paris-Sud, 91400 Orsay, France. · Medical Oncology Department, Institut Curie, Saint Cloud, Paris, France; Université Paris Descartes, Sorbonne Paris Cite, Paris, France. · Pubmed 28279941
  • Residual Tumor & Response to Treatment Laboratory, RT2Lab, Translational Research Department, PSL Research University, Institut Curie, Paris. · INSERM, U932 Immunity and Cancer, Paris. · Department of Medical Oncology, Institut Curie, Paris. · Faculty of Medicine, Paris Descartes University, Paris. · Departments of Surgery, Institut Curie, Paris. · Department of Pathology, Institut Curie, Paris, France. · Equipe d'Accueil 7285, Risk and Safety in Clinical Medicine for Women and Perinatal Health, University Versailles-Saint-Quentin, 2 av de la source de la Biévre, 78180 Montigny-le-Bretonneux, France. · Pubmed 28911063
2016
  • Institut Curie, PSL Research University, Translational Research Department, INSERM, U932 Immunity and Cancer, Residual Tumor & Response to Treatment Laboratory (RT2Lab), Paris, France. · Department of Surgery, Institut Curie, Paris, France. · Department of Tumor Biology, Institut Curie, Paris, France. · Mines Paristech, PSL-Research University, CBIO-Centre for Computational Biology, Mines ParisTech, Fontainebleau, France. · U900, INSERM, Institut Curie, Paris, France. · Laboratoire de Mathématiques et Modélisation d'Evry, Université d'Évry Val d'Essonne, Evry, France. · Pubmed 28005906
  • Institut Curie, PSL Research University, Translational Research Department, INSERM, U932 Immunity and Cancer, Residual Tumor & Response to Treatment Laboratory (RT2Lab), F-75248, Paris, France. · Biostatistics Department, Institut Curie, Paris 75005, France. · Department of Surgery, Institut Curie, Paris F-75248, France. · Department of Medical Oncology, Institut Curie, Paris, France. · Department of Tumor Biology, Institut Curie, Paris 75005, France. · Pubmed 26657653
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 21 total) written by Anne-sophie Hamy about Breast Neoplasms:

  • Neoadjuvant treatment for intermediate/high-risk HER2-positive and triple-negative breast cancers: no longer an 'option' but an ethical obligation. 2019
  • A multivariate Th17 metagene for prognostic stratification in T cell non-inflamed triple negative breast cancer. 2019
  • Impact of time to local recurrence on the occurrence of metastasis in breast cancer patients treated with neoadjuvant chemotherapy: A random forest survival approach. 2019
  • Neoadjuvant treatment: the future of patients with breast cancer. 2018
  • (no title) 2018
  • Chemosensitivity, tumor infiltrating lymphocytes (TILs), and survival of postpartum PABC patients treated by neoadjuvant chemotherapy. 2018
  • Lymphovascular invasion after neoadjuvant chemotherapy is strongly associated with poor prognosis in breast carcinoma. 2018
  • Long-term outcome of the REMAGUS 02 trial, a multicenter randomised phase II trial in locally advanced breast cancer patients treated with neoadjuvant chemotherapy with or without celecoxib or trastuzumab according to HER2 status. 2017
  • Stromal lymphocyte infiltration after neoadjuvant chemotherapy is associated with aggressive residual disease and lower disease-free survival in HER2-positive breast cancer. 2017
  • A Stromal Immune Module Correlated with the Response to Neoadjuvant Chemotherapy, Prognosis and Lymphocyte Infiltration in HER2-Positive Breast Carcinoma Is Inversely Correlated with Hormonal Pathways. 2016
Show List of Full Article Records
Google Searches

Learn more about Anne-sophie Hamy using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Institut Curie
Sorbonne University
INSERM France
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Institut Curie
2019
  • Université Libre de Bruxelles, Institut Jules Bordet, Bruxelles, Belgium. · Residual Tumor & Response to Treatment Laboratory, PSL Research University, Paris, France. · Breast and Gynecologic Cancer and Reconstructive Surgery Team, Institut Curie, Paris, France. · Pubmed 31231570
  • Institut Curie, PSL Research University, Paris, France. · Immunity and Cancer, Integrative Biology of Human Dendritic Cells and T Cells Laboratory, UMR 932 Immunity and Cancer, INSERM, Paris, France. · Stress and cancer laboratory, U830 Genetics and Biology of cancers, INSERM, Paris, France. · U900, Unit of biometry, INSERM, Paris, France. · Departement of translational research, Residual tumor and response to treatment laboratory (RT2Lab), UMR 932 Immunity and Cancer, INSERM, Paris, France. · Departement of Surgical Oncology, Institut Curie, Paris, France. · Diagnostic and Theranostic medicine division, Institut Curie, Paris, France. · Department of Biopathology, U934, INSERM, Paris, France. · Center of Clinical Investigation, CIC IGR-Curie 1428, Paris, France. · Pubmed 31428522
  • Department of Surgery, Institut Curie, Paris, France. · Residual Tumour & Response to Treatment Laboratory, RT2Lab, PSL Research University, Translational Research Department, Institut Curie, Paris, France. · INSERM, U932 Immunity and Cancer, Paris, France. · Department of Surgery, Institut Gustave Roussy, Villejuif, France. · Department of Gynaecology and Obstetrics, Geneva University Hospitals, Geneva, Switzerland. · Department of Medical Oncology, Institut Curie, Paris, France. · Paris Descartes University, Paris, France. · Pubmed 30673703
2018
  • Residual Tumor and Response to Treatment Laboratory, RT2Lab, PSL Research University, INSERM, U932 Immunity and Cancer, Institut Curie, Paris, France. · Breast and Gynecologic Cancer and Reconstructive Surgery Team, Institut Curie, Paris, France. · Institut Jules Bordet, Université Libre de Bruxelles, Bruxelles, Belgium. · Pubmed 29862051
  • Molecular Oncology Unit, Assistance Publique-Hôpitaux de Paris, University Saint-Louis Hospital, Paris, France · University Paris-Diderot, Sorbonne Paris Cité, INSERM/CNRS UMR944/7212, Paris, France. · PSL Research University, Translational Research Department INSERM U932, Immunity and Cancer, Residual Tumor & Response to Treatment Laboratory (RT2 Lab), Curie Institute, Paris, France. · Molecular Oncology Unit, Assistance Publique-Hôpitaux de Paris, University Saint-Louis Hospital, Paris, France. · Translational Research Laboratory, Gustave Roussy Cancer Center, Villejuif, France. · Pathology Department, Curie Institute, Paris, France. · Pathology Department, Gustave Roussy Cancer Center, Villejuif, France. · Pathology Department, Assistance Publique-Hôpitaux de Paris, University Saint-Louis Hospital, Paris, France. · Tumor Biology Department, Curie Institute, Saint-Cloud, France. · Medical Oncology Department, Curie Institute, Paris, France. · University Paris-Descartes, Sorbonne Paris Cité, Paris, France. · Breast Disease Unit, Assistance Publique-Hôpitaux de Paris, University Saint-Louis Hospital, Paris, France. · Medical Oncology Department, Curie Institute, Saint-Cloud, France. · Centre for Therapeutic Innovations in Oncology and Hematology, Assistance Publique-Hôpitaux de Paris, Saint-Louis Hospital, Paris, France. · UMR 8081 "IM4R", Université Paris Sud, Paris, France. · Pharmacogenomics Unit, Curie Institute, Paris, France. · Pubmed 29491076
  • Department of Surgery, Institut Curie, 26 rue d'Ulm, 75005 Paris, France. Electronic address: · Department of Surgery, Institut Curie, 26 rue d'Ulm, 75005 Paris, France. Electronic address: · Department of Pathology, Centre René Huguenin- Institut Curie, 35 Rue Dailly, 92210 St Cloud, France. Electronic address: · Department of Surgery, Institut Curie, 26 rue d'Ulm, 75005 Paris, France. Electronic address: · Port-Royal Maternity Unit, 123 Boulevard de Port Royal, 75014 Paris, France. Electronic address: · Department of Surgery, Institut Curie, 26 rue d'Ulm, 75005 Paris, France. Electronic address: · Department of Gynecology and Obstetrics, Geneva University Hospitals, Rue Gabrielle-Perret-Gentil 4, 1205 Geneva, Switzerland. Electronic address: · Department of Pathology, Centre René Huguenin- Institut Curie, 35 Rue Dailly, 92210 St Cloud, France. Electronic address: · Department of Surgery, Institut Curie, 26 rue d'Ulm, 75005 Paris, France; Residual Tumor & Response to Treatment Laboratory, RT2Lab, Translational Research Department, PSL Research University, INSERM, U932 Immunity and Cancer, Institut Curie, 26 rue d'Ulm, Paris, France. Electronic address: · Residual Tumor & Response to Treatment Laboratory, RT2Lab, Translational Research Department, PSL Research University, INSERM, U932 Immunity and Cancer, Institut Curie, 26 rue d'Ulm, Paris, France. Electronic address: · Pubmed 30179779
  • Translational Research Department, INSERM, U932, Immunity and Cancer, Residual Tumor & Response to Treatment Laboratory, RT2Lab, Institut Curie, PSL Research University, 26, rue d'Ulm, 75248, Paris, France. · Department of Surgery, Institut Curie, PSL Research University, 26 rue d'Ulm, 75248, Paris, France. · Department of Gynecology and Obstetrics, Geneva University Hospitals, 30 bd de la Cluse, 1205, Geneva, Switzerland. · Department of Medical Informatics and Data, Institut Curie, PSL Research University, 26 rue d'Ulm, 75248, Paris, France. · Department of Medical Oncology, Institut Curie, PSL Research University, 26 rue d'Ulm, 75248, Paris, France. · Department of Pathology, Institut Curie, PSL Research University, 26 rue d'Ulm, 75248, Paris, France. · Department of Medical Oncology, Hôpital René Huguenin, 35, rue Dailly, 92210, Saint-Cloud, France. · Department of Pathology, Hôpital René Huguenin, 35, rue Dailly, 92210, Saint-Cloud, France. · Department of Surgery, Hôpital René Huguenin, 35, rue Dailly, 92210, Saint-Cloud, France. · Equipe d'Accueil 7285, Risk and Safety in Clinical Medicine for Women and Perinatal Health, University Versailles-Saint-Quentin, 2 av de la source de la Bièvre, 78180, Montigny-Le-Bretonneux, France. · Translational Research Department, INSERM, U932, Immunity and Cancer, Residual Tumor & Response to Treatment Laboratory, RT2Lab, Institut Curie, PSL Research University, 26, rue d'Ulm, 75248, Paris, France. · Department of Surgery, Institut Curie, PSL Research University, 26 rue d'Ulm, 75248, Paris, France. · Pubmed 29374852
2017
  • AP-HP, Hôpital Saint-Louis, Breast Disease Unit, University Paris Diderot, 75475 Paris, France. Electronic address: · Institut Curie, PSL Research University, Translational Research Department, INSERM, U932 Immunity and Cancer, Residual Tumor & Response to Treatment Laboratory (RT2Lab), Paris, France. · Medical Oncology Department, Gustave Roussy, Cancer Center Villejuif, France. · Medical Oncology Department, Institut Curie, Saint Cloud, Paris, France. · Biostatistics Department, Institut Curie, Paris, France. · Tumor Biology Department, Institut Curie, Saint Cloud, Paris, France. · Pathology Department, Gustave Roussy, Cancer Center Villejuif, France. · AP-HP, Hôpital Saint-Louis, Pathology Department, University Paris Diderot, Paris, France. · Department of Surgery, Gustave Roussy, Cancer Center Villejuif, France. · Center for Therapeutic Innovations in Oncology and Haematology (CITOH), APHP, Hôpital Saint-Louis, Paris, France. · AP-HP, Hôpital Saint-Louis, Breast Disease Unit, University Paris Diderot, 75475 Paris, France. · Institut Curie, PSL Research University, Translational Research Department, INSERM, U932 Immunity and Cancer, Residual Tumor & Response to Treatment Laboratory (RT2Lab), Paris, France; Department of Surgery, Institut Curie, Paris, France. · AP-HP, Hôpital Saint-Louis, Breast Disease Unit, University Paris Diderot, 75475 Paris, France; Center for Therapeutic Innovations in Oncology and Haematology (CITOH), APHP, Hôpital Saint-Louis, Paris, France. · UMR 8081 'IR4M', Université Paris-Sud, 91400 Orsay, France. · Medical Oncology Department, Institut Curie, Saint Cloud, Paris, France; Université Paris Descartes, Sorbonne Paris Cite, Paris, France. · Pubmed 28279941
  • Residual Tumor & Response to Treatment Laboratory, RT2Lab, Translational Research Department, PSL Research University, Institut Curie, Paris. · INSERM, U932 Immunity and Cancer, Paris. · Department of Medical Oncology, Institut Curie, Paris. · Faculty of Medicine, Paris Descartes University, Paris. · Departments of Surgery, Institut Curie, Paris. · Department of Pathology, Institut Curie, Paris, France. · Equipe d'Accueil 7285, Risk and Safety in Clinical Medicine for Women and Perinatal Health, University Versailles-Saint-Quentin, 2 av de la source de la Biévre, 78180 Montigny-le-Bretonneux, France. · Pubmed 28911063
2016
  • Institut Curie, PSL Research University, Translational Research Department, INSERM, U932 Immunity and Cancer, Residual Tumor & Response to Treatment Laboratory (RT2Lab), Paris, France. · Department of Surgery, Institut Curie, Paris, France. · Department of Tumor Biology, Institut Curie, Paris, France. · Mines Paristech, PSL-Research University, CBIO-Centre for Computational Biology, Mines ParisTech, Fontainebleau, France. · U900, INSERM, Institut Curie, Paris, France. · Laboratoire de Mathématiques et Modélisation d'Evry, Université d'Évry Val d'Essonne, Evry, France. · Pubmed 28005906
  • Department of Biostatistics, Institut Curie, Paris, France. · Pharmacogenomics Unit, Department of Genetics, Institut Curie, Paris, France. · APHP Molecular Oncology Unit, Hôpital Saint Louis, Paris Diderot University, 1 Avenue Claude Vellefaux, 75010, Paris, France. · Biology Department, Institut Gustave Roussy, Villejuif, France. · APHP Pathology Department, Hôpital Saint Louis, Paris Diderot University, Paris, France. · Pathology Department, Hôpital René-Huguenin, Institut Curie, Saint-Cloud, France. · Pathology Department, Institut Gustave Roussy, Villejuif, France. · Pathology Department, Institut Curie, Paris, France. · APHP, Centre for Therapeutic Innovation, Saint-Louis Hospital, Paris, France. · APHP Molecular Oncology Unit, Hôpital Saint Louis, Paris Diderot University, 1 Avenue Claude Vellefaux, 75010, Paris, France. · Pubmed 27592112
  • Department of Surgery, Institut Curie, 75005, Paris, France. · Breast Unit, Belfast City Hospital, Lisburn Road, Belfast, BT9 7AB, Northern Ireland. · Department of Medical Oncology, 75005, Institut Curie, Paris, France. · Paris Descartes University, 75006, Paris, France. · Department of Tumor Biology, Institut Curie, 75005, Paris, France. · Department of Radiotherapy, Institut Curie, 75005, Paris, France. · Residual Tumor and Response to Treatment Lab, Translational Research Department, Institut Curie, 75005, Paris, France. · UMR932 Immunity and Cancer, INSERM, Institut Curie, 75005, Paris, France. · Pubmed 27494111
  • Institut Curie, PSL Research University, Translational Research Department, INSERM, U932 Immunity and Cancer, Residual Tumor & Response to Treatment Laboratory (RT2Lab), F-75248, Paris, France. · Biostatistics Department, Institut Curie, Paris 75005, France. · Department of Surgery, Institut Curie, Paris F-75248, France. · Department of Medical Oncology, Institut Curie, Paris, France. · Department of Tumor Biology, Institut Curie, Paris 75005, France. · Pubmed 26657653
2014
  • Department of Nuclear Medicine, Saint-Louis Hospital, Paris, France; B2T, Doctoral School, IUH, University of Paris VII, France. Electronic address: · Department of Nuclear Medicine, CHU Bordeaux, University of Bordeaux, France. · Breast Diseases Unit and Department of Medical Oncology, Saint-Louis Hospital, Paris, France. · Breast Diseases Unit and Department of Medical Oncology, Saint-Louis Hospital, Paris, France; Department of Biostatistics, Institut Curie, Paris, France. · Department of Biostatistics, Institut Curie, Paris, France. · Department of Nuclear Medicine, Saint-Louis Hospital, Paris, France; B2T, Doctoral School, IUH, University of Paris VII, France. · Department of Pathology, Saint-Louis Hospital, Paris, France. · Department of Biochemistry, Saint-Louis Hospital, Paris, France. · Breast Diseases Unit and Department of Medical Oncology, Saint-Louis Hospital, Paris, France; Centre for Therapeutic Innovation, Saint Louis Hospital, Paris, France. · INSERM, UMR 1101 LaTIM, Brest, France. · Pubmed 24841218
Sorbonne University
2019
  • Institut Curie, PSL Research University, Paris, France. · Immunity and Cancer, Integrative Biology of Human Dendritic Cells and T Cells Laboratory, UMR 932 Immunity and Cancer, INSERM, Paris, France. · Stress and cancer laboratory, U830 Genetics and Biology of cancers, INSERM, Paris, France. · U900, Unit of biometry, INSERM, Paris, France. · Departement of translational research, Residual tumor and response to treatment laboratory (RT2Lab), UMR 932 Immunity and Cancer, INSERM, Paris, France. · Departement of Surgical Oncology, Institut Curie, Paris, France. · Diagnostic and Theranostic medicine division, Institut Curie, Paris, France. · Department of Biopathology, U934, INSERM, Paris, France. · Center of Clinical Investigation, CIC IGR-Curie 1428, Paris, France. · Pubmed 31428522
  • Department of Surgery, Institut Curie, Paris, France. · Residual Tumour & Response to Treatment Laboratory, RT2Lab, PSL Research University, Translational Research Department, Institut Curie, Paris, France. · INSERM, U932 Immunity and Cancer, Paris, France. · Department of Surgery, Institut Gustave Roussy, Villejuif, France. · Department of Gynaecology and Obstetrics, Geneva University Hospitals, Geneva, Switzerland. · Department of Medical Oncology, Institut Curie, Paris, France. · Paris Descartes University, Paris, France. · Pubmed 30673703
2018
  • Molecular Oncology Unit, Assistance Publique-Hôpitaux de Paris, University Saint-Louis Hospital, Paris, France · University Paris-Diderot, Sorbonne Paris Cité, INSERM/CNRS UMR944/7212, Paris, France. · PSL Research University, Translational Research Department INSERM U932, Immunity and Cancer, Residual Tumor & Response to Treatment Laboratory (RT2 Lab), Curie Institute, Paris, France. · Molecular Oncology Unit, Assistance Publique-Hôpitaux de Paris, University Saint-Louis Hospital, Paris, France. · Translational Research Laboratory, Gustave Roussy Cancer Center, Villejuif, France. · Pathology Department, Curie Institute, Paris, France. · Pathology Department, Gustave Roussy Cancer Center, Villejuif, France. · Pathology Department, Assistance Publique-Hôpitaux de Paris, University Saint-Louis Hospital, Paris, France. · Tumor Biology Department, Curie Institute, Saint-Cloud, France. · Medical Oncology Department, Curie Institute, Paris, France. · University Paris-Descartes, Sorbonne Paris Cité, Paris, France. · Breast Disease Unit, Assistance Publique-Hôpitaux de Paris, University Saint-Louis Hospital, Paris, France. · Medical Oncology Department, Curie Institute, Saint-Cloud, France. · Centre for Therapeutic Innovations in Oncology and Hematology, Assistance Publique-Hôpitaux de Paris, Saint-Louis Hospital, Paris, France. · UMR 8081 "IM4R", Université Paris Sud, Paris, France. · Pharmacogenomics Unit, Curie Institute, Paris, France. · Pubmed 29491076
  • Department of Surgery, Institut Curie, 26 rue d'Ulm, 75005 Paris, France. Electronic address: · Department of Surgery, Institut Curie, 26 rue d'Ulm, 75005 Paris, France. Electronic address: · Department of Pathology, Centre René Huguenin- Institut Curie, 35 Rue Dailly, 92210 St Cloud, France. Electronic address: · Department of Surgery, Institut Curie, 26 rue d'Ulm, 75005 Paris, France. Electronic address: · Port-Royal Maternity Unit, 123 Boulevard de Port Royal, 75014 Paris, France. Electronic address: · Department of Surgery, Institut Curie, 26 rue d'Ulm, 75005 Paris, France. Electronic address: · Department of Gynecology and Obstetrics, Geneva University Hospitals, Rue Gabrielle-Perret-Gentil 4, 1205 Geneva, Switzerland. Electronic address: · Department of Pathology, Centre René Huguenin- Institut Curie, 35 Rue Dailly, 92210 St Cloud, France. Electronic address: · Department of Surgery, Institut Curie, 26 rue d'Ulm, 75005 Paris, France; Residual Tumor & Response to Treatment Laboratory, RT2Lab, Translational Research Department, PSL Research University, INSERM, U932 Immunity and Cancer, Institut Curie, 26 rue d'Ulm, Paris, France. Electronic address: · Residual Tumor & Response to Treatment Laboratory, RT2Lab, Translational Research Department, PSL Research University, INSERM, U932 Immunity and Cancer, Institut Curie, 26 rue d'Ulm, Paris, France. Electronic address: · Pubmed 30179779
  • Translational Research Department, INSERM, U932, Immunity and Cancer, Residual Tumor & Response to Treatment Laboratory, RT2Lab, Institut Curie, PSL Research University, 26, rue d'Ulm, 75248, Paris, France. · Department of Surgery, Institut Curie, PSL Research University, 26 rue d'Ulm, 75248, Paris, France. · Department of Gynecology and Obstetrics, Geneva University Hospitals, 30 bd de la Cluse, 1205, Geneva, Switzerland. · Department of Medical Informatics and Data, Institut Curie, PSL Research University, 26 rue d'Ulm, 75248, Paris, France. · Department of Medical Oncology, Institut Curie, PSL Research University, 26 rue d'Ulm, 75248, Paris, France. · Department of Pathology, Institut Curie, PSL Research University, 26 rue d'Ulm, 75248, Paris, France. · Department of Medical Oncology, Hôpital René Huguenin, 35, rue Dailly, 92210, Saint-Cloud, France. · Department of Pathology, Hôpital René Huguenin, 35, rue Dailly, 92210, Saint-Cloud, France. · Department of Surgery, Hôpital René Huguenin, 35, rue Dailly, 92210, Saint-Cloud, France. · Equipe d'Accueil 7285, Risk and Safety in Clinical Medicine for Women and Perinatal Health, University Versailles-Saint-Quentin, 2 av de la source de la Bièvre, 78180, Montigny-Le-Bretonneux, France. · Translational Research Department, INSERM, U932, Immunity and Cancer, Residual Tumor & Response to Treatment Laboratory, RT2Lab, Institut Curie, PSL Research University, 26, rue d'Ulm, 75248, Paris, France. · Department of Surgery, Institut Curie, PSL Research University, 26 rue d'Ulm, 75248, Paris, France. · Pubmed 29374852
2017
  • AP-HP, Hôpital Saint-Louis, Breast Disease Unit, University Paris Diderot, 75475 Paris, France. Electronic address: · Institut Curie, PSL Research University, Translational Research Department, INSERM, U932 Immunity and Cancer, Residual Tumor & Response to Treatment Laboratory (RT2Lab), Paris, France. · Medical Oncology Department, Gustave Roussy, Cancer Center Villejuif, France. · Medical Oncology Department, Institut Curie, Saint Cloud, Paris, France. · Biostatistics Department, Institut Curie, Paris, France. · Tumor Biology Department, Institut Curie, Saint Cloud, Paris, France. · Pathology Department, Gustave Roussy, Cancer Center Villejuif, France. · AP-HP, Hôpital Saint-Louis, Pathology Department, University Paris Diderot, Paris, France. · Department of Surgery, Gustave Roussy, Cancer Center Villejuif, France. · Center for Therapeutic Innovations in Oncology and Haematology (CITOH), APHP, Hôpital Saint-Louis, Paris, France. · AP-HP, Hôpital Saint-Louis, Breast Disease Unit, University Paris Diderot, 75475 Paris, France. · Institut Curie, PSL Research University, Translational Research Department, INSERM, U932 Immunity and Cancer, Residual Tumor & Response to Treatment Laboratory (RT2Lab), Paris, France; Department of Surgery, Institut Curie, Paris, France. · AP-HP, Hôpital Saint-Louis, Breast Disease Unit, University Paris Diderot, 75475 Paris, France; Center for Therapeutic Innovations in Oncology and Haematology (CITOH), APHP, Hôpital Saint-Louis, Paris, France. · UMR 8081 'IR4M', Université Paris-Sud, 91400 Orsay, France. · Medical Oncology Department, Institut Curie, Saint Cloud, Paris, France; Université Paris Descartes, Sorbonne Paris Cite, Paris, France. · Pubmed 28279941
  • Residual Tumor & Response to Treatment Laboratory, RT2Lab, Translational Research Department, PSL Research University, Institut Curie, Paris. · INSERM, U932 Immunity and Cancer, Paris. · Department of Medical Oncology, Institut Curie, Paris. · Faculty of Medicine, Paris Descartes University, Paris. · Departments of Surgery, Institut Curie, Paris. · Department of Pathology, Institut Curie, Paris, France. · Equipe d'Accueil 7285, Risk and Safety in Clinical Medicine for Women and Perinatal Health, University Versailles-Saint-Quentin, 2 av de la source de la Biévre, 78180 Montigny-le-Bretonneux, France. · Pubmed 28911063
2016
  • Institut Curie, PSL Research University, Translational Research Department, INSERM, U932 Immunity and Cancer, Residual Tumor & Response to Treatment Laboratory (RT2Lab), Paris, France. · Department of Surgery, Institut Curie, Paris, France. · Department of Tumor Biology, Institut Curie, Paris, France. · Mines Paristech, PSL-Research University, CBIO-Centre for Computational Biology, Mines ParisTech, Fontainebleau, France. · U900, INSERM, Institut Curie, Paris, France. · Laboratoire de Mathématiques et Modélisation d'Evry, Université d'Évry Val d'Essonne, Evry, France. · Pubmed 28005906
  • Institut Curie, PSL Research University, Translational Research Department, INSERM, U932 Immunity and Cancer, Residual Tumor & Response to Treatment Laboratory (RT2Lab), F-75248, Paris, France. · Biostatistics Department, Institut Curie, Paris 75005, France. · Department of Surgery, Institut Curie, Paris F-75248, France. · Department of Medical Oncology, Institut Curie, Paris, France. · Department of Tumor Biology, Institut Curie, Paris 75005, France. · Pubmed 26657653
INSERM France
2019
  • Institut Curie, PSL Research University, Paris, France. · Immunity and Cancer, Integrative Biology of Human Dendritic Cells and T Cells Laboratory, UMR 932 Immunity and Cancer, INSERM, Paris, France. · Stress and cancer laboratory, U830 Genetics and Biology of cancers, INSERM, Paris, France. · U900, Unit of biometry, INSERM, Paris, France. · Departement of translational research, Residual tumor and response to treatment laboratory (RT2Lab), UMR 932 Immunity and Cancer, INSERM, Paris, France. · Departement of Surgical Oncology, Institut Curie, Paris, France. · Diagnostic and Theranostic medicine division, Institut Curie, Paris, France. · Department of Biopathology, U934, INSERM, Paris, France. · Center of Clinical Investigation, CIC IGR-Curie 1428, Paris, France. · Pubmed 31428522
  • Department of Surgery, Institut Curie, Paris, France. · Residual Tumour & Response to Treatment Laboratory, RT2Lab, PSL Research University, Translational Research Department, Institut Curie, Paris, France. · INSERM, U932 Immunity and Cancer, Paris, France. · Department of Surgery, Institut Gustave Roussy, Villejuif, France. · Department of Gynaecology and Obstetrics, Geneva University Hospitals, Geneva, Switzerland. · Department of Medical Oncology, Institut Curie, Paris, France. · Paris Descartes University, Paris, France. · Pubmed 30673703
2018
  • Molecular Oncology Unit, Assistance Publique-Hôpitaux de Paris, University Saint-Louis Hospital, Paris, France · University Paris-Diderot, Sorbonne Paris Cité, INSERM/CNRS UMR944/7212, Paris, France. · PSL Research University, Translational Research Department INSERM U932, Immunity and Cancer, Residual Tumor & Response to Treatment Laboratory (RT2 Lab), Curie Institute, Paris, France. · Molecular Oncology Unit, Assistance Publique-Hôpitaux de Paris, University Saint-Louis Hospital, Paris, France. · Translational Research Laboratory, Gustave Roussy Cancer Center, Villejuif, France. · Pathology Department, Curie Institute, Paris, France. · Pathology Department, Gustave Roussy Cancer Center, Villejuif, France. · Pathology Department, Assistance Publique-Hôpitaux de Paris, University Saint-Louis Hospital, Paris, France. · Tumor Biology Department, Curie Institute, Saint-Cloud, France. · Medical Oncology Department, Curie Institute, Paris, France. · University Paris-Descartes, Sorbonne Paris Cité, Paris, France. · Breast Disease Unit, Assistance Publique-Hôpitaux de Paris, University Saint-Louis Hospital, Paris, France. · Medical Oncology Department, Curie Institute, Saint-Cloud, France. · Centre for Therapeutic Innovations in Oncology and Hematology, Assistance Publique-Hôpitaux de Paris, Saint-Louis Hospital, Paris, France. · UMR 8081 "IM4R", Université Paris Sud, Paris, France. · Pharmacogenomics Unit, Curie Institute, Paris, France. · Pubmed 29491076
  • Department of Surgery, Institut Curie, 26 rue d'Ulm, 75005 Paris, France. Electronic address: · Department of Surgery, Institut Curie, 26 rue d'Ulm, 75005 Paris, France. Electronic address: · Department of Pathology, Centre René Huguenin- Institut Curie, 35 Rue Dailly, 92210 St Cloud, France. Electronic address: · Department of Surgery, Institut Curie, 26 rue d'Ulm, 75005 Paris, France. Electronic address: · Port-Royal Maternity Unit, 123 Boulevard de Port Royal, 75014 Paris, France. Electronic address: · Department of Surgery, Institut Curie, 26 rue d'Ulm, 75005 Paris, France. Electronic address: · Department of Gynecology and Obstetrics, Geneva University Hospitals, Rue Gabrielle-Perret-Gentil 4, 1205 Geneva, Switzerland. Electronic address: · Department of Pathology, Centre René Huguenin- Institut Curie, 35 Rue Dailly, 92210 St Cloud, France. Electronic address: · Department of Surgery, Institut Curie, 26 rue d'Ulm, 75005 Paris, France; Residual Tumor & Response to Treatment Laboratory, RT2Lab, Translational Research Department, PSL Research University, INSERM, U932 Immunity and Cancer, Institut Curie, 26 rue d'Ulm, Paris, France. Electronic address: · Residual Tumor & Response to Treatment Laboratory, RT2Lab, Translational Research Department, PSL Research University, INSERM, U932 Immunity and Cancer, Institut Curie, 26 rue d'Ulm, Paris, France. Electronic address: · Pubmed 30179779
  • Translational Research Department, INSERM, U932, Immunity and Cancer, Residual Tumor & Response to Treatment Laboratory, RT2Lab, Institut Curie, PSL Research University, 26, rue d'Ulm, 75248, Paris, France. · Department of Surgery, Institut Curie, PSL Research University, 26 rue d'Ulm, 75248, Paris, France. · Department of Gynecology and Obstetrics, Geneva University Hospitals, 30 bd de la Cluse, 1205, Geneva, Switzerland. · Department of Medical Informatics and Data, Institut Curie, PSL Research University, 26 rue d'Ulm, 75248, Paris, France. · Department of Medical Oncology, Institut Curie, PSL Research University, 26 rue d'Ulm, 75248, Paris, France. · Department of Pathology, Institut Curie, PSL Research University, 26 rue d'Ulm, 75248, Paris, France. · Department of Medical Oncology, Hôpital René Huguenin, 35, rue Dailly, 92210, Saint-Cloud, France. · Department of Pathology, Hôpital René Huguenin, 35, rue Dailly, 92210, Saint-Cloud, France. · Department of Surgery, Hôpital René Huguenin, 35, rue Dailly, 92210, Saint-Cloud, France. · Equipe d'Accueil 7285, Risk and Safety in Clinical Medicine for Women and Perinatal Health, University Versailles-Saint-Quentin, 2 av de la source de la Bièvre, 78180, Montigny-Le-Bretonneux, France. · Translational Research Department, INSERM, U932, Immunity and Cancer, Residual Tumor & Response to Treatment Laboratory, RT2Lab, Institut Curie, PSL Research University, 26, rue d'Ulm, 75248, Paris, France. · Department of Surgery, Institut Curie, PSL Research University, 26 rue d'Ulm, 75248, Paris, France. · Pubmed 29374852
2017
  • AP-HP, Hôpital Saint-Louis, Breast Disease Unit, University Paris Diderot, 75475 Paris, France. Electronic address: · Institut Curie, PSL Research University, Translational Research Department, INSERM, U932 Immunity and Cancer, Residual Tumor & Response to Treatment Laboratory (RT2Lab), Paris, France. · Medical Oncology Department, Gustave Roussy, Cancer Center Villejuif, France. · Medical Oncology Department, Institut Curie, Saint Cloud, Paris, France. · Biostatistics Department, Institut Curie, Paris, France. · Tumor Biology Department, Institut Curie, Saint Cloud, Paris, France. · Pathology Department, Gustave Roussy, Cancer Center Villejuif, France. · AP-HP, Hôpital Saint-Louis, Pathology Department, University Paris Diderot, Paris, France. · Department of Surgery, Gustave Roussy, Cancer Center Villejuif, France. · Center for Therapeutic Innovations in Oncology and Haematology (CITOH), APHP, Hôpital Saint-Louis, Paris, France. · AP-HP, Hôpital Saint-Louis, Breast Disease Unit, University Paris Diderot, 75475 Paris, France. · Institut Curie, PSL Research University, Translational Research Department, INSERM, U932 Immunity and Cancer, Residual Tumor & Response to Treatment Laboratory (RT2Lab), Paris, France; Department of Surgery, Institut Curie, Paris, France. · AP-HP, Hôpital Saint-Louis, Breast Disease Unit, University Paris Diderot, 75475 Paris, France; Center for Therapeutic Innovations in Oncology and Haematology (CITOH), APHP, Hôpital Saint-Louis, Paris, France. · UMR 8081 'IR4M', Université Paris-Sud, 91400 Orsay, France. · Medical Oncology Department, Institut Curie, Saint Cloud, Paris, France; Université Paris Descartes, Sorbonne Paris Cite, Paris, France. · Pubmed 28279941
  • Residual Tumor & Response to Treatment Laboratory, RT2Lab, Translational Research Department, PSL Research University, Institut Curie, Paris. · INSERM, U932 Immunity and Cancer, Paris. · Department of Medical Oncology, Institut Curie, Paris. · Faculty of Medicine, Paris Descartes University, Paris. · Departments of Surgery, Institut Curie, Paris. · Department of Pathology, Institut Curie, Paris, France. · Equipe d'Accueil 7285, Risk and Safety in Clinical Medicine for Women and Perinatal Health, University Versailles-Saint-Quentin, 2 av de la source de la Biévre, 78180 Montigny-le-Bretonneux, France. · Pubmed 28911063
2016
  • Institut Curie, PSL Research University, Translational Research Department, INSERM, U932 Immunity and Cancer, Residual Tumor & Response to Treatment Laboratory (RT2Lab), Paris, France. · Department of Surgery, Institut Curie, Paris, France. · Department of Tumor Biology, Institut Curie, Paris, France. · Mines Paristech, PSL-Research University, CBIO-Centre for Computational Biology, Mines ParisTech, Fontainebleau, France. · U900, INSERM, Institut Curie, Paris, France. · Laboratoire de Mathématiques et Modélisation d'Evry, Université d'Évry Val d'Essonne, Evry, France. · Pubmed 28005906
  • Institut Curie, PSL Research University, Translational Research Department, INSERM, U932 Immunity and Cancer, Residual Tumor & Response to Treatment Laboratory (RT2Lab), F-75248, Paris, France. · Biostatistics Department, Institut Curie, Paris 75005, France. · Department of Surgery, Institut Curie, Paris F-75248, France. · Department of Medical Oncology, Institut Curie, Paris, France. · Department of Tumor Biology, Institut Curie, Paris 75005, France. · Pubmed 26657653
Hopitaux Universitaires Saint-Louis Lariboisiere Fernand-Widal
2016
  • Centre des Maladies du Sein, Hôpital Saint Louis, AP-HP, 1 Avenue Claude Vellefaux, 75010, Paris, France. Electronic address: · Hôtel Dieu, APHP, Centre d'épidémiologie, 75004 Paris, France; Inserm 75475 Paris Cedex 10, France. · Centre des Maladies du Sein, Hôpital Saint Louis, AP-HP, 1 Avenue Claude Vellefaux, 75010, Paris, France. · Service de Biochimie Endocrinienne et Oncologique, UF de Nutrigénétique, Groupe Hospitalier Pitié Salpêtrière, AP-HP, 47-83 Bd de l'Hôpital, 75651 Paris Cedex 13, France; U872 INSERM Equipe 4, Différenciation Intestinale et Métabolisme Lipidique, 15 Rue de l'Ecole de Médecine 75006 Paris, France. · Pubmed 26803206
2014
  • Centre des Maladies du Sein, Hôpital Saint Louis, AP-HP, 1 Avenue Claude Vellefaux, 75010, Paris, France. Electronic address: · Hôtel Dieu, APHP, Centre d'épidémiologie clinique, 75004 Paris, France; Inserm, 75475 Paris Cedex 10, France. · Centre des Maladies du Sein, Hôpital Saint Louis, AP-HP, 1 Avenue Claude Vellefaux, 75010, Paris, France. · Service de Biologie Cellulaire, Hôpital Saint Louis, AP-HP, 1 Avenue Claude Vellefaux, 75010, Paris, France. · Service de Biochimie Endocrinienne et Oncologique, UF de Nutrigénétique, Groupe Hospitalier Pitié Salpêtrière, AP-HP, 47-83 Bd de l'Hôpital, 75651 Paris Cedex 13, France; U872 INSERM Equipe 4, Différenciation Intestinale et Métabolisme Lipidique, 15 Rue de l'Ecole de Médecine 75006 Paris, France. · Service de Biochimie, Laboratoire des Urgences et Gardes, Hôpital Saint Louis, AP-HP, 1 Avenue Claude Vellefaux, 75010, Paris, France. · Service de Biologie de la Reproduction, Groupe Hospitalier Pitié-Salpêtrière, AP-HP, Université Paris VI, 47-83 Bd de l'Hôpital, 75651 Paris Cedex 13, France. · Pubmed 25246112
  • Department of Nuclear Medicine, Saint-Louis Hospital, Paris, France; B2T, Doctoral School, IUH, University of Paris VII, France. Electronic address: · Department of Nuclear Medicine, CHU Bordeaux, University of Bordeaux, France. · Breast Diseases Unit and Department of Medical Oncology, Saint-Louis Hospital, Paris, France. · Breast Diseases Unit and Department of Medical Oncology, Saint-Louis Hospital, Paris, France; Department of Biostatistics, Institut Curie, Paris, France. · Department of Biostatistics, Institut Curie, Paris, France. · Department of Nuclear Medicine, Saint-Louis Hospital, Paris, France; B2T, Doctoral School, IUH, University of Paris VII, France. · Department of Pathology, Saint-Louis Hospital, Paris, France. · Department of Biochemistry, Saint-Louis Hospital, Paris, France. · Breast Diseases Unit and Department of Medical Oncology, Saint-Louis Hospital, Paris, France; Centre for Therapeutic Innovation, Saint Louis Hospital, Paris, France. · INSERM, UMR 1101 LaTIM, Brest, France. · Pubmed 24841218
  • AP-HP, Hôpital Saint-Louis, Breast Disease Unit, University Paris Diderot, Paris 75475, France. · AP-HP, Hôpital Saint-Louis, Biostatistic Department, Paris 75475, France. · 1] AP-HP, Hôpital Saint-Louis, Molecular Biology Department, Paris 75475, France [2] INSERM/CNRS/University Paris Diderot UMR 944/7212, Paris 75475, France. · 1] AP-HP, Hôpital Saint-Louis, Pathology Department, Paris 75475, France [2] University Paris Diderot, UMR-S-728 INSERM, Paris 75475, France. · AP-HP, Hôpital Saint-Louis, Radiology Department, Paris 75475, France. · Pubmed 24569467
2015
  • Department of Nuclear Medicine, Saint-Louis Hospital, 1 avenue Claude Vellefaux, 75475, Paris Cedex 10, France, · Pubmed 25432784
2012
  • Service de Médecine Nucléaire, Hôpital Saint-Louis, Assistance publique Hôpitaux de Paris, 1 Ave Claude Vellefaux, 75475 Paris Cedex 10, France. · Pubmed 23243198
Universite Paris 7 Diderot
2016
  • Centre des Maladies du Sein, Hôpital Saint Louis, AP-HP, 1 Avenue Claude Vellefaux, 75010, Paris, France. Electronic address: · Hôtel Dieu, APHP, Centre d'épidémiologie, 75004 Paris, France; Inserm 75475 Paris Cedex 10, France. · Centre des Maladies du Sein, Hôpital Saint Louis, AP-HP, 1 Avenue Claude Vellefaux, 75010, Paris, France. · Service de Biochimie Endocrinienne et Oncologique, UF de Nutrigénétique, Groupe Hospitalier Pitié Salpêtrière, AP-HP, 47-83 Bd de l'Hôpital, 75651 Paris Cedex 13, France; U872 INSERM Equipe 4, Différenciation Intestinale et Métabolisme Lipidique, 15 Rue de l'Ecole de Médecine 75006 Paris, France. · Pubmed 26803206
2014
  • Centre des Maladies du Sein, Hôpital Saint Louis, AP-HP, 1 Avenue Claude Vellefaux, 75010, Paris, France. Electronic address: · Hôtel Dieu, APHP, Centre d'épidémiologie clinique, 75004 Paris, France; Inserm, 75475 Paris Cedex 10, France. · Centre des Maladies du Sein, Hôpital Saint Louis, AP-HP, 1 Avenue Claude Vellefaux, 75010, Paris, France. · Service de Biologie Cellulaire, Hôpital Saint Louis, AP-HP, 1 Avenue Claude Vellefaux, 75010, Paris, France. · Service de Biochimie Endocrinienne et Oncologique, UF de Nutrigénétique, Groupe Hospitalier Pitié Salpêtrière, AP-HP, 47-83 Bd de l'Hôpital, 75651 Paris Cedex 13, France; U872 INSERM Equipe 4, Différenciation Intestinale et Métabolisme Lipidique, 15 Rue de l'Ecole de Médecine 75006 Paris, France. · Service de Biochimie, Laboratoire des Urgences et Gardes, Hôpital Saint Louis, AP-HP, 1 Avenue Claude Vellefaux, 75010, Paris, France. · Service de Biologie de la Reproduction, Groupe Hospitalier Pitié-Salpêtrière, AP-HP, Université Paris VI, 47-83 Bd de l'Hôpital, 75651 Paris Cedex 13, France. · Pubmed 25246112
  • Department of Nuclear Medicine, Saint-Louis Hospital, Paris, France; B2T, Doctoral School, IUH, University of Paris VII, France. Electronic address: · Department of Nuclear Medicine, CHU Bordeaux, University of Bordeaux, France. · Breast Diseases Unit and Department of Medical Oncology, Saint-Louis Hospital, Paris, France. · Breast Diseases Unit and Department of Medical Oncology, Saint-Louis Hospital, Paris, France; Department of Biostatistics, Institut Curie, Paris, France. · Department of Biostatistics, Institut Curie, Paris, France. · Department of Nuclear Medicine, Saint-Louis Hospital, Paris, France; B2T, Doctoral School, IUH, University of Paris VII, France. · Department of Pathology, Saint-Louis Hospital, Paris, France. · Department of Biochemistry, Saint-Louis Hospital, Paris, France. · Breast Diseases Unit and Department of Medical Oncology, Saint-Louis Hospital, Paris, France; Centre for Therapeutic Innovation, Saint Louis Hospital, Paris, France. · INSERM, UMR 1101 LaTIM, Brest, France. · Pubmed 24841218
  • AP-HP, Hôpital Saint-Louis, Breast Disease Unit, University Paris Diderot, Paris 75475, France. · AP-HP, Hôpital Saint-Louis, Biostatistic Department, Paris 75475, France. · 1] AP-HP, Hôpital Saint-Louis, Molecular Biology Department, Paris 75475, France [2] INSERM/CNRS/University Paris Diderot UMR 944/7212, Paris 75475, France. · 1] AP-HP, Hôpital Saint-Louis, Pathology Department, Paris 75475, France [2] University Paris Diderot, UMR-S-728 INSERM, Paris 75475, France. · AP-HP, Hôpital Saint-Louis, Radiology Department, Paris 75475, France. · Pubmed 24569467
2015
  • Department of Nuclear Medicine, Saint-Louis Hospital, 1 avenue Claude Vellefaux, 75475, Paris Cedex 10, France, · Pubmed 25432784
2012
  • Service de Médecine Nucléaire, Hôpital Saint-Louis, Assistance publique Hôpitaux de Paris, 1 Ave Claude Vellefaux, 75475 Paris Cedex 10, France. · Pubmed 23243198
Yearly article counts 03425141100
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.